Ethynylandrostanediol

N/A

Report date: 2025/11/28 11:35:45
NME

Base Information

Drug NameEthynylandrostanediol
Drug Alias NameApoptoneHE-3235
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHarbor
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarbor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A